| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Departments of Pathology, Physiology, and Cellular Biophysics, Surgery and Medicine,*College of Physicians & Surgeons, Columbia University, New York, New York; the Department of Internal Medicine IV,Friedrich-Schiller-University, Jena, Germany; the Department of Medicine I,University of Heidelberg, Germany; and the Department of Molecular Immunology,Division of Tumor Immunology, German Cancer Research Center, Heidelberg, Germany
Diabetic nephropathy ensues from events involving earliest changes in the glomeruli and podocytes, followed by accumulation of extracellular matrix in the mesangium. Postulated mechanisms include roles for vascular endothelial growth factor (VEGF), produced by podocytes and contributing to enhanced excretion of urinary albumin and recruitment/activation of inflammatory cells, and transforming growth factor-ß (TGF-ß), elicited largely from mesangial cells and driving production of extracellular matrix. RAGE, a receptor for advanced glycation endproducts (AGEs) and S100/calgranulins, displays enhanced expression in podocytes of genetically diabetic db/db mice by age 13 weeks. RAGE-bearing podocytes express high levels of VEGF by this time, in parallel with enhanced recruitment of mononuclear phagocytes to the glomeruli; events prevented by blockade of RAGE. By age 27 weeks, soluble RAGE-treated db/db mice displayed diminished albuminuria and glomerulosclerosis, and improved renal function. Diabetic homozygous RAGE null mice failed to develop significantly increased mesangial matrix expansion or thickening of the glomerular basement membrane. We propose that activation of RAGE contributes to expression of VEGF and enhanced attraction/activation of inflammatory cells in the diabetic glomerulus, thereby setting the stage for mesangial activation and TGF-ß production; processes which converge to cause albuminuria and glomerulosclerosis.
This article has been cited by other articles:
 |
|
 |
|
  G. Wolf, N. Muller, M. Busch, G. Eidner, C. Kloos, W. Hunger-Battefeld, and U. A Muller Diabetic foot syndrome and renal function in type 1 and 2 diabetes mellitus show close association Nephrol. Dial. Transplant., June 1, 2009; 24(6): 1896 - 1901. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Z. Kalea, N. Reiniger, H. Yang, M. Arriero, A. M. Schmidt, and B. I. Hudson Alternative splicing of the murine receptor for advanced glycation end-products (RAGE) gene FASEB J, June 1, 2009; 23(6): 1766 - 1774. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Fujimura, S.-i. Yamagishi, S. Ueda, K. Fukami, R. Shibata, Y. Matsumoto, Y. Kaida, A. Hayashida, K. Koike, T. Matsui, et al. Administration of pigment epithelium-derived factor (PEDF) reduces proteinuria by suppressing decreased nephrin and increased VEGF expression in the glomeruli of adriamycin-injected rats Nephrol. Dial. Transplant., May 1, 2009; 24(5): 1397 - 1406. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. Coughlan, D. R. Thorburn, S. A. Penfold, A. Laskowski, B. E. Harcourt, K. C. Sourris, A. L.Y. Tan, K. Fukami, V. Thallas-Bonke, P. P. Nawroth, et al. RAGE-Induced Cytosolic ROS Promote Mitochondrial Superoxide Generation in Diabetes J. Am. Soc. Nephrol., April 1, 2009; 20(4): 742 - 752. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. F. Wei, Q. G. Zhou, F. F. Hou, B. Y. Liu, and M. Liang Advanced oxidation protein products induce mesangial cell perturbation through PKC-dependent activation of NADPH oxidase Am J Physiol Renal Physiol, February 1, 2009; 296(2): F427 - F437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Shi, L. Yu, C. Chiu, Y. Sun, J. Chen, G. Khitrov, M. Merkenschlager, L. B. Holzman, W. Zhang, P. Mundel, et al. Podocyte-Selective Deletion of Dicer Induces Proteinuria and Glomerulosclerosis J. Am. Soc. Nephrol., November 1, 2008; 19(11): 2159 - 2169. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Soro-Paavonen, A. M.D. Watson, J. Li, K. Paavonen, A. Koitka, A. C. Calkin, D. Barit, M. T. Coughlan, B. G. Drew, G. I. Lancaster, et al. Receptor for Advanced Glycation End Products (RAGE) Deficiency Attenuates the Development of Atherosclerosis in Diabetes Diabetes, September 1, 2008; 57(9): 2461 - 2469. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Ruster, T. Bondeva, S. Franke, M. Forster, and G. Wolf Advanced glycation end-products induce cell cycle arrest and hypertrophy in podocytes Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2179 - 2191. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. G. Bucciarelli, R. Ananthakrishnan, Y. C. Hwang, M. Kaneko, F. Song, D. R. Sell, C. Strauch, V. M. Monnier, S. F. Yan, A. M. Schmidt, et al. RAGE and Modulation of Ischemic Injury in the Diabetic Myocardium Diabetes, July 1, 2008; 57(7): 1941 - 1951. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Forbes, M. T. Coughlan, and M. E. Cooper Oxidative Stress as a Major Culprit in Kidney Disease in Diabetes Diabetes, June 1, 2008; 57(6): 1446 - 1454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. I. Hudson, A. M. Carter, E. Harja, A. Z. Kalea, M. Arriero, H. Yang, P. J. Grant, and A. M. Schmidt Identification, classification, and expression of RAGE gene splice variants FASEB J, May 1, 2008; 22(5): 1572 - 1580. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Guo, R. Ananthakrishnan, W. Qu, Y. Lu, N. Reiniger, S. Zeng, W. Ma, R. Rosario, S. F. Yan, R. Ramasamy, et al. RAGE Mediates Podocyte Injury in Adriamycin-induced Glomerulosclerosis J. Am. Soc. Nephrol., May 1, 2008; 19(5): 961 - 972. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Chang, T. Wendt, W. Qu, L. Kong, Y. S. Zou, A. M. Schmidt, and S.-F. Yan Oxygen Deprivation Triggers Upregulation of Early Growth Response-1 by the Receptor for Advanced Glycation End Products Circ. Res., April 25, 2008; 102(8): 905 - 913. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-Y. Goh and M. E. Cooper The Role of Advanced Glycation End Products in Progression and Complications of Diabetes J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1143 - 1152. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Toth, L. L. Rong, C. Yang, J. Martinez, F. Song, N. Ramji, V. Brussee, W. Liu, J. Durand, M. D. Nguyen, et al. Receptor for Advanced Glycation End Products (RAGEs) and Experimental Diabetic Neuropathy Diabetes, April 1, 2008; 57(4): 1002 - 1017. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Aleshin, R. Ananthakrishnan, Q. Li, R. Rosario, Y. Lu, W. Qu, F. Song, S. Bakr, M. Szabolcs, V. D'Agati, et al. RAGE modulates myocardial injury consequent to LAD infarction via impact on JNK and STAT signaling in a murine model Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1823 - H1832. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Origlia, M. Righi, S. Capsoni, A. Cattaneo, F. Fang, D. M. Stern, J. X. Chen, A. M. Schmidt, O. Arancio, S. D. Yan, et al. Receptor for Advanced Glycation End Product-Dependent Activation of p38 Mitogen-Activated Protein Kinase Contributes to Amyloid-{beta}-Mediated Cortical Synaptic Dysfunction J. Neurosci., March 26, 2008; 28(13): 3521 - 3530. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Hiwatashi, S. Ueno, K. Abeyama, F. Kubo, M. Sakoda, I. Maruyama, M. Hamanoue, S. Natsugoe, and T. Aikou A Novel Function of the Receptor for Advanced Glycation End-Products (RAGE) in Association with Tumorigenesis and Tumor Differentiation of HCC Ann. Surg. Oncol., March 1, 2008; 15(3): 923 - 933. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Englert, L. E. Hanford, N. Kaminski, J. M. Tobolewski, R. J. Tan, C. L. Fattman, L. Ramsgaard, T. J. Richards, I. Loutaev, P. P. Nawroth, et al. A Role for the Receptor for Advanced Glycation End Products in Idiopathic Pulmonary Fibrosis Am. J. Pathol., March 1, 2008; 172(3): 583 - 591. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Thallas-Bonke, S. R. Thorpe, M. T. Coughlan, K. Fukami, F. Y.T. Yap, K. C. Sourris, S. A. Penfold, L. A. Bach, M. E. Cooper, and J. M. Forbes Inhibition of NADPH Oxidase Prevents Advanced Glycation End Product-Mediated Damage in Diabetic Nephropathy Through a Protein Kinase C-{alpha}-Dependent Pathway Diabetes, February 1, 2008; 57(2): 460 - 469. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Moser, D. D. Desai, M. P. Downie, Y. Chen, S. F. Yan, K. Herold, A. M. Schmidt, and R. Clynes Receptor for Advanced Glycation End Products Expression on T Cells Contributes to Antigen-Specific Cellular Expansion In Vivo J. Immunol., December 15, 2007; 179(12): 8051 - 8058. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Xia, H. Wang, S. Munk, H. Frecker, H. J. Goldberg, I. G. Fantus, and C. I. Whiteside Reactive oxygen species, PKC-beta1, and PKC-{zeta} mediate high-glucose-induced vascular endothelial growth factor expression in mesangial cells Am J Physiol Endocrinol Metab, November 1, 2007; 293(5): E1280 - E1288. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Marsche, B. Weigle, W. Sattler, and E. Malle Soluble RAGE blocks scavenger receptor CD36-mediated uptake of hypochlorite-modified low-density lipoprotein FASEB J, October 1, 2007; 21(12): 3075 - 3082. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Nakamura, H. Li, A. Adijiang, M. Pischetsrieder, and T. Niwa Pyridoxal phosphate prevents progression of diabetic nephropathy Nephrol. Dial. Transplant., August 1, 2007; 22(8): 2165 - 2174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Nasr and V. D. D'Agati Nodular Glomerulosclerosis in the Nondiabetic Smoker J. Am. Soc. Nephrol., July 1, 2007; 18(7): 2032 - 2036. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-J. Chen, H.-Y. Peng, C.-L. Cheng, C.-H. Chen, J.-M. Liao, Y.-C. Ho, J.-T. Liou, K.-C. Tung, T.-H. Hsu, and T.-B. Lin Acute unilateral ureteral distension inhibits glutamate-dependent spinal pelvic-urethra reflex potentiation via GABAergic neurotransmission in anesthetized rats Am J Physiol Renal Physiol, March 1, 2007; 292(3): F1007 - F1015. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Zen, C. X.-J. Chen, Y.-T. Chen, R. Wilton, and Y. Liu Receptor for Advanced Glycation Endproducts Mediates Neutrophil Migration across Intestinal Epithelium J. Immunol., February 15, 2007; 178(4): 2483 - 2490. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Vincent, L. Perrone, K. A. Sullivan, C. Backus, A. M. Sastry, C. Lastoskie, and E. L. Feldman Receptor for Advanced Glycation End Products Activation Injures Primary Sensory Neurons via Oxidative Stress Endocrinology, February 1, 2007; 148(2): 548 - 558. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Coughlan, V. Thallas-Bonke, J. Pete, D. M. Long, A. Gasser, D. C. K. Tong, M. Arnstein, S. R. Thorpe, M. E. Cooper, and J. M. Forbes Combination Therapy with the Advanced Glycation End Product Cross-Link Breaker, Alagebrium, and Angiotensin Converting Enzyme Inhibitors in Diabetes: Synergy or Redundancy? Endocrinology, February 1, 2007; 148(2): 886 - 895. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Uribarri and K. R. Tuttle Advanced Glycation End Products and Nephrotoxicity of High-Protein Diets Clin. J. Am. Soc. Nephrol., November 1, 2006; 1(6): 1293 - 1299. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. G. Raman, P. L. Sappington, R. Yang, R. M. Levy, J. M. Prince, S. Liu, S. K. Watkins, A. M. Schmidt, T. R. Billiar, and M. P. Fink The role of RAGE in the pathogenesis of intestinal barrier dysfunction after hemorrhagic shock Am J Physiol Gastrointest Liver Physiol, October 1, 2006; 291(4): G556 - G565. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. J. Zhao, S. Wang, H. Cheng, M.-z. Zhang, T. Takahashi, A. B. Fogo, M. D. Breyer, and R. C. Harris Endothelial Nitric Oxide Synthase Deficiency Produces Accelerated Nephropathy in Diabetic Mice J. Am. Soc. Nephrol., October 1, 2006; 17(10): 2664 - 2669. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-M. Myint, Y. Yamamoto, T. Doi, I. Kato, A. Harashima, H. Yonekura, T. Watanabe, H. Shinohara, M. Takeuchi, K. Tsuneyama, et al. RAGE Control of Diabetic Nephropathy in a Mouse Model: Effects of RAGE Gene Disruption and Administration of Low-Molecular Weight Heparin Diabetes, September 1, 2006; 55(9): 2510 - 2522. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Humpert, S. Kopf, Z. Djuric, T. Wendt, M. Morcos, P. P. Nawroth, and A. Bierhaus Plasma sRAGE Is Independently Associated With Urinary Albumin Excretion in Type 2 Diabetes Diabetes Care, May 1, 2006; 29(5): 1111 - 1113. [Full Text] [PDF]
|
|
|
|
|
|
K. Ichinose, Y. Maeshima, Y. Yamamoto, M. Kinomura, K. Hirokoshi, H. Kitayama, Y. Takazawa, H. Sugiyama, Y. Yamasaki, N. Agata, et al. 2-(8-Hydroxy-6-Methoxy-1-Oxo-1H-2-Benzopyran-3-yl) Propionic Acid, an Inhibitor of Angiogenesis, Ameliorates Renal Alterations in Obese Type 2 Diabetic Mice. Diabetes, May 1, 2006; 55(5): 1232 - 1242. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. G. Bucciarelli, M. Kaneko, R. Ananthakrishnan, E. Harja, L. K. Lee, Y. C. Hwang, S. Lerner, S. Bakr, Q. Li, Y. Lu, et al. Receptor for Advanced-Glycation End Products: Key Modulator of Myocardial Ischemic Injury Circulation, March 7, 2006; 113(9): 1226 - 1234. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J N Jensen, L. Denner, B. F Schrijvers, R. G Tilton, R. Rasch, and A. Flyvbjerg Renal effects of a neutralising RAGE-antibody in long-term streptozotocin-diabetic mice. J. Endocrinol., March 1, 2006; 188(3): 493 - 501. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Gu, S. Hagiwara, Q. Fan, M. Tanimoto, M. Kobata, M. Yamashita, T. Nishitani, T. Gohda, Z. Ni, J. Qian, et al. Role of receptor for advanced glycation end-products and signalling events in advanced glycation end-product-induced monocyte chemoattractant protein-1 expression in differentiated mouse podocytes Nephrol. Dial. Transplant., February 1, 2006; 21(2): 299 - 313. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Hall Prevention of Progression in Diabetic Nephropathy Diabetes Spectr, January 1, 2006; 19(1): 18 - 24. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Schwenger, C. Morath, A. Salava, K. Amann, Y. Seregin, R. Deppisch, E. Ritz, A. Bierhaus, P. P. Nawroth, and M. Zeier Damage to the Peritoneal Membrane by Glucose Degradation Products Is Mediated by the Receptor for Advanced Glycation End-Products J. Am. Soc. Nephrol., January 1, 2006; 17(1): 199 - 207. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Genuth, W. Sun, P. Cleary, D. R. Sell, W. Dahms, J. Malone, W. Sivitz, V. M. Monnier, and for the DCCT Skin Collagen Ancillary Study Group Glycation and Carboxymethyllysine Levels in Skin Collagen Predict the Risk of Future 10-Year Progression of Diabetic Retinopathy and Nephropathy in the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications Participants With Type 1 Diabetes Diabetes, November 1, 2005; 54(11): 3103 - 3111. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Waanders, W. L. Greven, J. W. Baynes, S. R. Thorpe, A. B. Kramer, R. Nagai, N. Sakata, H. van Goor, and G. Navis Renal accumulation of pentosidine in non-diabetic proteinuria-induced renal damage in rats Nephrol. Dial. Transplant., October 1, 2005; 20(10): 2060 - 2070. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Bohlender, S. Franke, G. Stein, and G. Wolf Advanced glycation end products and the kidney Am J Physiol Renal Physiol, October 1, 2005; 289(4): F645 - F659. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Forbes, S. R. Thorpe, V. Thallas-Bonke, J. Pete, M. C. Thomas, E. R. Deemer, S. Bassal, A. El-Osta, D. M. Long, S. Panagiotopoulos, et al. Modulation of Soluble Receptor for Advanced Glycation End Products by Angiotensin-Converting Enzyme-1 Inhibition in Diabetic Nephropathy J. Am. Soc. Nephrol., August 1, 2005; 16(8): 2363 - 2372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Harris Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy: It's All the RAGE J. Am. Soc. Nephrol., August 1, 2005; 16(8): 2251 - 2253. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Ramasamy, S. J. Vannucci, S. S. D. Yan, K. Herold, S. F. Yan, and A. M. Schmidt Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation Glycobiology, July 1, 2005; 15(7): 16R - 28R. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kankova, A. Stejskalova, M. Hertlova, and V. Znojil Haplotype analysis of the RAGE gene: identification of a haplotype marker for diabetic nephropathy in type 2 diabetes mellitus Nephrol. Dial. Transplant., June 1, 2005; 20(6): 1093 - 1102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Wolf, S. Chen, and F. N. Ziyadeh From the Periphery of the Glomerular Capillary Wall Toward the Center of Disease: Podocyte Injury Comes of Age in Diabetic Nephropathy Diabetes, June 1, 2005; 54(6): 1626 - 1634. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Breyer, E. Bottinger, F. C. Brosius III, T. M. Coffman, R. C. Harris, C. W. Heilig, K. Sharma, and for the AMDCC Mouse Models of Diabetic Nephropathy J. Am. Soc. Nephrol., January 1, 2005; 16(1): 27 - 45. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. F. Schrijvers, A. S. De Vriese, and A. Flyvbjerg From Hyperglycemia to Diabetic Kidney Disease: The Role of Metabolic, Hemodynamic, Intracellular Factors and Growth Factors/Cytokines Endocr. Rev., December 1, 2004; 25(6): 971 - 1010. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-L. Wautier and A. M. Schmidt Protein Glycation: A Firm Link to Endothelial Cell Dysfunction Circ. Res., August 6, 2004; 95(3): 233 - 238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Lassila, K. K. Seah, T. J. Allen, V. Thallas, M. C. Thomas, R. Candido, W. C. Burns, J. M. Forbes, A. C. Calkin, M. E. Cooper, et al. Accelerated Nephropathy in Diabetic Apolipoprotein E-Knockout Mouse: Role of Advanced Glycation End Products J. Am. Soc. Nephrol., August 1, 2004; 15(8): 2125 - 2138. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ida, K. Ishibashi, K. Reiser, L. M. Hjelmeland, and J. T. Handa Ultrastructural Aging of the RPE-Bruch's Membrane-Choriocapillaris Complex in the D-Galactose-Treated Mouse Invest. Ophthalmol. Vis. Sci., July 1, 2004; 45(7): 2348 - 2354. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Forbes, L. T. L. Yee, V. Thallas, M. Lassila, R. Candido, K. A. Jandeleit-Dahm, M. C. Thomas, W. C. Burns, E. K. Deemer, S. R. Thorpe, et al. Advanced Glycation End Product Interventions Reduce Diabetes-Accelerated Atherosclerosis Diabetes, July 1, 2004; 53(7): 1813 - 1823. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-F. Yan, R. Ramasamy, L. G Bucciarelli, T. Wendt, L. K Lee, B. I Hudson, D. M Stenr, E. Lalla, S. Du Yan, L. L. Rong, et al. RAGE and its ligands: a lasting memory in diabetic complications? Diabetes and Vascular Disease Research, May 1, 2004; 1(1): 10 - 20. [Abstract] [PDF]
|
|
|
|
|
|
P. J. Thornalley Glycation, receptor-mediated cell activation and vascular complications of diabetes Diabetes and Vascular Disease Research, May 1, 2004; 1(1): 21 - 22. [PDF]
|
|
|
|
|
|
A. Flyvbjerg, L. Denner, B. F. Schrijvers, R. G. Tilton, T. H. Mogensen, S. R. Paludan, and R. Rasch Long-Term Renal Effects of a Neutralizing RAGE Antibody in Obese Type 2 Diabetic Mice Diabetes, January 1, 2004; 53(1): 166 - 172. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. F. Yan, R. Ramasamy, Y. Naka, and A. M. Schmidt Glycation, Inflammation, and RAGE: A Scaffold for the Macrovascular Complications of Diabetes and Beyond Circ. Res., December 12, 2003; 93(12): 1159 - 1169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. T. Bolick, M. E. Hatley, S. Srinivasan, C. C. Hedrick, and J. L. Nadler Lisofylline, a Novel Antiinflammatory Compound, Protects Mesangial Cells from Hyperglycemia- and Angiotensin II-Mediated Extracellular Matrix Deposition Endocrinology, December 1, 2003; 144(12): 5227 - 5231. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Chavakis, A. Bierhaus, N. Al-Fakhri, D. Schneider, S. Witte, T. Linn, M. Nagashima, J. Morser, B. Arnold, K. T. Preissner, et al. The Pattern Recognition Receptor (RAGE) Is a Counterreceptor for Leukocyte Integrins: A Novel Pathway for Inflammatory Cell Recruitment J. Exp. Med., November 17, 2003; 198(10): 1507 - 1515. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
